J & H Besta Corp. of Hicksville, New York, was informed by the U.S. Food and Drug Administration (FDA) that agency lab analysis of <"http://www.yourlawyer.com/practice_areas/defective_drugs">Slim-30 Herb Supplement, Lot 6032101, distributed by the company was found to contain undeclared Desmethyl Sibutramine, similar in structure to Sibutramine. Sibutramine is an FDA-approved drug used as an appetite suppressant for weight loss. The FDA has not approved the Slim-30 Herbal Supplement, therefore, the safety and efficacy of the product is unknown.
On July 16, 2010, J & H Besta recalled Lot/Code 032009. J & H Besta is now expanding the recall action to include Lot 6032101.
The FDA advises that this product poses a threat to consumers because Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Slim-30 Herb Supplement is marketed as a Natural Herb for Weight Loss. Slim-30 Herb Supplement is packaged in plastic bottles containing 30 capsules per bottle and bears UPC 8 31457 005009 2. The product was sold to distributors and retail stores nationwide and via Internet sales.
To date, no illnesses or injuries have been reported to the company to date in connection with this product. This recall is being conducted with the knowledge of the FDA.
J & H Besta Corp. is discontinuing distribution of Lot/Code 6032101.
Consumers should not consume Slim-30 Herb Supplement and should return it immediately to the place of purchase for a full refund. Consumers with questions should contact Jason Wang at J & H Besta at 516-735-1436, Monday through Friday, from 10:00 a.m. to 5:30 p.m., Eastern Daily Time.
Any adverse reactions experienced with the use of this product may be reported to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program online [at www.fda.gov/MedWatch/report.htm9], by phone 1-800-332-1088 [1-800-FDA-1088], or by returning the postage-paid FDA form 3500 [which may be downloaded from the MedWatch “Download Forms10″ page], by mail [to address on the pre-addressed form] or fax [1-800-FDA-0178].